 "A medic provides medicine as part of Covid-19 treatment at Sri H. N. Reliance Foundation Hospital in collaboration with the Brihanmumbai Municipal Corporation (BMC), in Mumbai. Photo: PTI")
The Indian Council of Medical Research has started a multi-centre clinical trial to assess the safety of the convalescent plasma to limit any coronavirus related complications.
"ICMR has initiated a multi-centre clinical trial to assess the safety and efficacy of convalescent plasma to limit Covid-19 associated complications in moderate disease," read an official statement by the ICMR.
The trial has been titled as "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit Covid-19 Associated Complications in Moderate Disease."
